HomeCLDX • NASDAQ
add
Celldex Therapeutics Inc
Previous close
$29.43
Year range
$14.40 - $31.31
Market cap
1.96B USD
Avg Volume
858.67K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 121.00K | -89.70% |
Operating expense | 11.94M | 16.35% |
Net income | -81.32M | -72.68% |
Net profit margin | -67.20K | -1,576.82% |
Earnings per share | -1.22 | -71.83% |
EBITDA | -86.34M | -56.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 518.57M | -28.50% |
Total assets | 582.98M | -26.42% |
Total liabilities | 55.82M | 23.12% |
Total equity | 527.16M | — |
Shares outstanding | 66.57M | — |
Price to book | 3.72 | — |
Return on assets | -35.39% | — |
Return on capital | -38.55% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -81.32M | -72.68% |
Cash from operations | -63.94M | -96.88% |
Cash from investing | 55.42M | 130.49% |
Cash from financing | 1.35M | 249.48% |
Net change in cash | -7.17M | 10.90% |
Free cash flow | -36.47M | -116.16% |
About
Founded
1983
Headquarters
Website
Employees
198
